Skip to main content
Back to 8VC

8VC's Life Science Portfolio

Browse 8 Life Science companies funded by 8VC. See funding amounts, founder contacts, and investment details.

Life Science Companies
8
Total Funding in Life Science
$185.4M

Life Science Portfolio Companies (8)

Export
BiotechnologyLife SciencePharmaceutical

ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.

Toronto, Canada
May 2026
$11.0M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

Cambridge, United States
May 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
Series E

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Big DataHealth CareLife SciencePersonal Health

Citizen Health is a personalized AI Advocate platform that helps patients understand and organize their medical information.

San Mateo, United States
August 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncologyPharmaceutical

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Durham, United States
April 2025
$19.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGenerative AILife SciencePharmaceutical

We are making biology programmable to transform health and sustainability for the benefit of all.

London, United Kingdom
February 2025
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Elegen is a biotechnology company that develops microfluidic technology.

San Carlos, United States
May 2024
$35.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsClinical TrialsLife Science

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

San Francisco, United States
February 2024
$50.0M
Series C

Founder Contacts

19,000+ verified contacts

Explore 8VC's Full Portfolio

View all companies funded by 8VC across every industry and funding stage.

View Full 8VC Portfolio